GlobeNewswire PharmaOriginal article
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
Data ReadoutpositiveTelomir-ZnPositive
AI Analysis
Summary
Telomir Pharmaceuticals announced research conducted with The Ohio State University showing Telomir-Zn demonstrated in-vitro anti-cancer activity against human and canine osteosarcoma cell growth.
Outcome Details
In-vitro research demonstrating inhibition of cell growth in human and canine osteosarcoma models
Importance:3/10
Sentiment:
0.60
osteosarcomain-vitroresearch collaborationoncologypreclinical
Read the original article
Published by GlobeNewswire Pharma on September 14, 2026 12:00 PM